P46370 4th Annual Bioprocess and Technology 2018
Download Brochure Request

Register your interest

Comments

Register your interest

Comments

4th Annual Bioprocess and Technology 2018

31 October – 2 November 2018, One Farrer Hotel & Spa, Singapore

Book Now Download Brochure

SPECIAL 1-FOR-1 OFFER ON NORMAL RATES FOR PHARMACEUTICAL AND BIOTECH COMPANIES*
LIMITED SEATS, APPLICABLE ONLY TO 2-DAY MAIN CONFERENCE DAYS.
SEE PRICING BELOW FOR MORE INFORMATION.

overview

From the need to rethink innovation, to adopting disruptive manufacturing technology, the biopharma industry is pushing the boundaries of excellence. Will future of bioprocess be disease or epidemic based? What trends will determine new directions for industry? The 4th Annual Bioprocess and Technology is back with Pharma and technology partner insights on bioprocess management as a whole, and manufacturing trends.

“Bioprocess and Technology is a very unique event with focus in Bioprocess related information relevant for APAC. I highly recommend attending this conference.”
Anita R Patil, Group Leader, Wockhardt Research

Conference Highlights

  • Regional Biopharma Companies – Case Studies on Bioprocess Management, Vaccine Manufacturing, Operations, QA/AC
  • Continuous ManufacturingTechnology and Business Case, Conventional Batch-based Processing Vs. Continuous Manufacturing
  • Quality and Consistency Standards – Balancing Standards, Product Development Strategies, CGMP
  • Regulatory ClarityInterpretation, Guidelines for Biologics, Harmonisation, Disease Surveillance
  • Bioprocess Technology SpotlightManufacturing Trends, Capital Spending, Quality & Risk, and Facilities
  • CMO Showcase – Quality Standards, Six Sigma and Validation at Sites

Choose your language

Part of

Biopharma Development & Production Asia >>

Co-Located Events

Bioprocess and Technology >>
Biopharma SCMInnovate >>
Biotech Investment Summit >>

agenda

8:00 am

Main Conference Registration and Morning Coffee

8:50 am

Chairperson’s Opening Remarks

BIOPHARMA DEVELOPMENT AND PRODUCTION 2018 OPENING PLENARY SESSIONS

9:00 am

  • M&A investment trends in life sciences
  • Exponential advances in technology optimising the supply chain
  • New Partnerships and trends-Biopharma focus
  • Key factors impacting future investments

9:30 am

  • Translational research to understand local unmet medical need
  • Addressing ethnic difference through innovative science and development strategies
  • Contributing to collaborative R&D ecosystem to ensure quality

10:00 am

  • AI applications in biopharma market value chain – R&D, clinical trials, business process management and supply chain
  • Using AI tools in pharma – How Asia is progressing?

10:30 am

11:15 am

Morning Networking and Refreshment Break End of Plenary Session. Bioprocess & Technology Continues

11:45 am

Chairperson’s Opening Remarks

PROCESS INTENSIFICATION AND COST-REDUCTION STRATEGIES

  • Technical CMC development for establishing an end-to-end bioprocess strategy
  • Process optimization and process intensification for better efficiency and speed to market
  • Developing an accelerated timeline for biologics development and bioproduction

12:10 pm

  • Integrating process and product design for superior manufacturing process control
  • Improving economies of scale for individual bioprocesses, to achieve operational efficiency
  • Utilizing disposable technologies and intensified processes to create cost-effective bioproduction

12:40 pm

  • Designing high-productivity and cost-effective biopharmaceutical production facilities
  • Utilizing disposable technologies and intensified processes to create manufacturing flexibility
  • Real-time monitoring of parameters to rectify deviants in time and reduce product changeover time

For speaking opportunities, please contact:
Siang-Yee, Tel: +65 65082446 | Email: siangyee.yeo@ibcasia.com.sg

1:00 pm

Networking Lunch

CELL THERAPY AND NOVEL BIOTHERAPEUTICS DISCOVERY

2:00 pm

  • A technology platform for enabling the development of ADCs, bispecifics and multi-binding antibodies in versatile configurations
  • Lead identification and optimization for higher affinity and reduction in potential immunogenicity
  • Enabling higher therapeutic index through optimal disease target engagement

2:30 pm

  • Showcasing a patented nanotechnology for in-situ isolation of donor stem cells
  • Reducing the carcinogenic risk of cultivating NSCs through a specific nanotechnology matrix
  • Improving harvest yield, function and safety for individualized stem cell therapies

3:00 pm

  • Developing novel mAbs and innovative biotherapeutics through Science Based Drug Discovery (SBDD) and Market-Oriented Drug Development (MODD)
  • Accelerating bio-drug development via public-private partnership through KBIO
  • Raising efficiency of new drug development and commercialization

3:30 pm

Afternoon Networking & Refreshment Break

4:00 pm

  • Exploring regenerative effects of BDACs and their demonstrating pericytic identity
  • Engineering BDACs to meet clinical requirements on quantity and short-term availability
  • Designing bio-instructive biomaterials to support BDAC growth and proliferation

LARGE-SCALE CELL CULTURE SYSTEMS AND UPSTREAM OPTIMIZATION

4:30 pm

  • Key considerations for scale-up of cell culture operations and tech transfer
  • Collaborating with global partners to ensure seamless alignment during tech transfer activities
  • In-process control methods for ensuring product safety and consistency

5:00 pm

  • Importance of glycosylation on therapeutic protein
  • Altering the glycans on antibody to enhance efficacy
  • Increasing half-life of biologics through enhancement of specific glycans

5:30 pm

  • Managing commercial scale production for cell-derived biotherapeutics
  • Critical parameters to control, key factors to consider
  • In-process control methods for ensuring cell culture stability and product consistency

6:00 pm

Networking Cocktail

8:50 am

Chairperson’s Opening Remarks

OPTIMIZING VIRAL CLEARANCE AND IMPROVING RECOVERY YIELD

9:00 am

  • Overcoming filter fouling in viral clearance studies
  • Critical aspects in virus filtration
  • Comparison of different filter vendors

9:30 am

  • HCPs form a major class of process-related impurities derived during bioproduction
  • Challenges of reducing HCPs to acceptable levels, key considerations for removal at various downstream stages
  • Innovative strategies for enhancing the removal of residual HCP to meet drug substance specifications

For speaking opportunities, please contact:
Siang-Yee Tel: +65 65082446 | Email: siangyee.yeo@ibcasia.com.sg

10:00 am

  • Comparison of current cell harvesting and clarification strategies for mAbs
  • Analyzation of how cell culture parameters influencing the harvesting performance
  • Development of a harvesting guide to take the right way from the beginning to reduce time to market

10:30 am

Morning Networking & Refreshment Break

ANALYTICAL METHOD DEVELOPMENT FOR PROCESS AND QUALITY CONTROL

11:00 am

  • Understanding the specific challenges for quality risk management in a single-use plant
  • Risk-based assessment and meeting key quality attributes for drug substances
  • Achieving quality and manufacturing goals, including site certification

For speaking opportunities, please contact:
Siang-Yee Tel: +65 65082446 | Email: siangyee.yeo@ibcasia.com.sg

11:30 am

  • Critical concepts and MS strategies for analytical method development
  • Introduction of bioinformatics strategies to enable expedient glyco-analysis
  • Application of such strategies to therapeutic recombinant glycoprotein drugs

12:00 pm

  • Ongoing quality improvement and monitoring efforts for site operations
  • Overcoming the challenges for data integrity in line with regulatory requirements
  • Ensuring a strong quality and compliance focus with key stakeholders, partners and suppliers

For speaking opportunities, please contact:
Siang-Yee Tel: +65 65082446 | Email: siangyee.yeo@ibcasia.com.sg

12:30 pm

Networking Lunch

OPERATIONAL EXCELLENCE AND SMART FACILITIES OF THE FUTURE

1:30 pm

  • Integrating process and product design for superior manufacturing process control
  • Utilizing disposable technologies and intensified processes to create cost-effective bioproduction
  • Process optimization and fluid integration of upstream and downstream processes

2:00 pm

  • Applying continuous process improvement activities in the biomanufacturing value-chain
  • Improving manufacturing operations through lean management approaches
  • Driving cost savings initiatives through deviation reduction initiatives

2:30 pm

  • Understanding the complexities and cost drivers associated with vaccine production
  • Strategic planning, design and setup of AJ Pharma Holding’s first vaccine facility in Malaysia
  • cGMP considerations and meeting up to international accreditation standards

3:00 pm

  • Process change to maximize raw material yield and improve yield ratio
  • Enhancing operational efficiency and streamlining bioproduction processes
  • Lean management strategies for single-use systems and reduction in OPEX

3:30 pm

Afternoon Networking & Refreshment Break

BIOPHARMA DEVELOPMENT AND PRODUCTION 2018 CLOSING PLENARY SESSIONS

4:00 pm

  • Reviewing latest disruptions in the biopharma industry
  • Re-thinking manufacturing productivity and quality
  • Connecting human resources, data, machines and networks for better outcomes
  • Impacts of Industry 4.0 on drug financing and investment outlook
  • Data management, product traceability and supply chain security

5:00 pm

Chairperson’s Summary and End of Main Conference Day Two

9:00 am

The workshop will give an overview on viral clearance principles and global regulatory requirements for all biopharmaceuticals like recombinants, vaccines, plasma products and animal/human tissue derived biologics. Best approaches for viral clearance studies particularly for recombinant products will be detailed and discussed and the effectiveness of frequently analyzed virus inactivation- and virus removal steps will be described.

Key learning outcomes:

  • Background on viral clearance
  • The right viral clearance study design
  • Viral clearance effectiveness

1:00 pm

End of workshop

pricing

Packages Price
2 Day ConferenceSGD $2895SGD $2695Early BirdEarly Bird
Extras Price
Pre-conference workshop SGD $800

Early Bird Rate: Register & Pay by 7 September 2018

Special 1-for-1 Offer on Normal Rates for Pharmaceutical and Biotech Companies*
Limited seats, applicable only to 2-day main conference days.
Email register@ibcasia.com.sg to find out more!

*The organizer reserves the right to determine the industry to which your company belongs, and to stop the promotion at any stage.

GROUP RATE: SGD 2,595
Register 2 Delegates and get 1 FREE PASS
Register 3 Delegates and get 2 FREE PASS
Register 5 Delegates and get 3 FREE PASS
(Group rate is based on normal rate of 2-day main conference package only)

For Group Registrations of more than 3 team members,
email info@ibcasia.com.sg or call +65 6508 2477

  • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)

Sponsorship

Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

speakers

Ming-Qiang Zhang

Vice-President, Research & Development, Amgen, China

Dr. Carl Firth

Founder and Chief Executive Officer, Aslan Pharmaceuticals Pte Ltd, Singapore

Piers Ingram

Chief Executive Officer, Hummingbird Bioscience, Singapore

Jinpian Diao-Piezunka

Head of Bioprocess Development, Sanofi, France

Jonathan Zhao

PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Ryan Viegas

Head of Logistics - APAC, Teva

Senior Representative from MERCK

Art Hsing-Mao Chu

Director of Research, Immunework, Taiwan

Ken Yung

Professor and Associate Head, Department of Biology, Hong Kong Baptist University, Hong Kong

Daeyoung Kim

Principal Researcher, Division of Discovery & Optimization, New Drug Development Center, Osong Medical Innovation Foundation (KBIO), Korea

Anna Maria Blocki

Assistant Professor, Institute for Tissue Engineering and Regenerative Medicine (ITERM), Hong Kong

Ziliang Liu

Biological Technology Transfer Supervisor, BeiGene, China

Pao Chun Lin

Associate Staff Scientist, Bioprocessing Technology Institute, Singapore

Praveen Gupta

Head of Upstream Process Development | Mammalian & Microbial | Biosimilars, Intas, India

Horst Ruppach

Scientific Director Viral Pathogen Safety, Charles River, Germany

Silke Bergheim-Pietza

Global Product Manager Pre- and Depth Filtration, Pall Biotech

Terry Nguyen-Khuong

Associate Staff Scientist, Bioprocessing Technology Institute, Singapore

Liang Tang

Vice President of Biologics Development and Manufacturing, WuXi Biologics, China

Venu Mallavarapu

Head, Operational Excellence, Lonza, Singapore

Joseph Albert

Chief Technical Officer – Engineering and Projects, AJ Pharma Holding, Malaysia

Christian Cater

Head of Operational Excellence, Roche, Singapore

when & where

31 Oct - 02 Nov 2018

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

contact

Still have a question?

Speaking Opportunities
Siang Yee
+65-6508 2446
SiangYee.Yeo@ibcasia.com.sg

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Yvonne.Leong@ibcasia.com.sg

Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg

sponsors

Partners

Supporting Association

STAY UPDATED ON OUR NEWS & EVENTS

IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more